Agenus, Inc. (AGEN)

3.79 -0.29 (-7.11%) USD  |  NASDAQ  |  Dec 12, 16:00
3.795 0.00 (0.00%) After-Hours: 20:00
More

Agenus Research and Development Expense (Annual): 155.53M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for AGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Inovio Pharmaceuticals, Inc. 77.22M
Cardiff Oncology, Inc. 36.85M
Armata Pharmaceuticals, Inc. 34.43M
AIM ImmunoTech, Inc. 6.149M
Protalix Biotherapeutics, Inc. 12.97M